Biomolecules | Free Full-Text | p53's Extended Reach: The Mutant p53 Secretome
Pathogenesis of TP53-mutated Acute Myeloid leukemia | Laboratory of Daniel C. Link, M.D. | Washington University in St. Louis
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden | Genome Medicine | Full Text
Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype - ScienceDirect
Frontiers | Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
Recent findings on molecular alterations in IDH1, TP53, and CASP9 in gliomagenesis | Biomedical Research and Therapy
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway: Cell
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis | Cell Death Discovery
Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma | NEJM
Recurrent somatic mutations reveal new insights into consequences of mutagenic processes in cancer | PLOS Computational Biology
Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling | PNAS
Rare Mutation of TP53 Gene Leaves People at Higher Risk for Multiple Cancers - Penn Medicine
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
Clinical implications of subclonal TP53 mutations in acute myeloid leukemia | Haematologica
Mutational processes shape the landscape of TP53 mutations in human cancer | Nature Genetics
An unexpected role for p53 in regulating cancer cell–intrinsic PD-1 by acetylation | Science Advances
The p53 network: cellular and systemic DNA damage responses in cancer and aging: Trends in Genetics
Frequency of p53 mutations in human cancers. (A) Schematic picture... | Download Scientific Diagram
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm | ACS Chemical Biology
Development of TP53 mutations over the course of therapy for acute myeloid leukemia - Alwash - 2021 - American Journal of Hematology - Wiley Online Library
Targeting a neoantigen derived from a common TP53 mutation | Science
Mutant p53 elicits context-dependent pro-tumorigenic phenotypes | Oncogene
IJMS | Free Full-Text | Do Mutations Turn p53 into an Oncogene?
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
